Follow
Antonello Di Paolo
Antonello Di Paolo
Verified email at unipi.it
Title
Cited by
Cited by
Year
Pharmacokinetic drug-drug interaction and their implication in clinical management
C Palleria, A Di Paolo, C Giofrè, C Caglioti, G Leuzzi, A Siniscalchi, ...
Journal of research in medical sciences: the official journal of Isfahan …, 2013
5282013
The pharmacological bases of the antiangiogenic activity of paclitaxel
G Bocci, A Di Paolo, R Danesi
Angiogenesis 16, 481-492, 2013
2062013
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer
A Falcone, G Masi, G Allegrini, R Danesi, E Pfanner, IM Brunetti, ...
Journal of clinical oncology 20 (19), 4006-4014, 2002
1932002
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients
A Di Paolo, R Danesi, A Falcone, L Cionini, F Vannozzi, G Masi, ...
Annals of oncology 12 (9), 1301-1306, 2001
1502001
Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).
R Danesi, C Agen, U Benelli, AD Paolo, D Nardini, G Bocci, F Basolo, ...
Clinical cancer research: an official journal of the American Association …, 1997
1361997
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5, 6-dihydrouracil after conventional and reduced test dose in cancer patients
G Bocci, R Danesi, A Di Paolo, F Innocenti, G Allegrini, A Falcone, ...
Clinical cancer research 6 (8), 3032-3037, 2000
1242000
Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study
C Scatena, M Roncella, A Di Paolo, P Aretini, M Menicagli, G Fanelli, ...
Frontiers in oncology 8, 452, 2018
1192018
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
G Bocci, A Falcone, A Fioravanti, P Orlandi, A Di Paolo, G Fanelli, ...
British journal of cancer 98 (10), 1619-1629, 2008
1132008
Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification
A Di Paolo, G Bocci
Current oncology reports 9, 109-114, 2007
1102007
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer
F Loupakis, C Cremolini, A Fioravanti, P Orlandi, L Salvatore, G Masi, ...
British journal of cancer 104 (8), 1262-1269, 2011
1082011
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post‐marketing clinical study on healthy volunteers
M Del Tacca, G Pasqualetti, A Di Paolo, A Virdis, G Massimetti, G Gori, ...
British journal of clinical pharmacology 68 (1), 34-42, 2009
992009
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer
R Danesi, F De Braud, S Fogli, TM De Pas, A Di Paolo, G Curigliano, ...
Pharmacological reviews 55 (1), 57-103, 2003
982003
Pharmacological issues of linezolid: an updated critical review
A Di Paolo, P Malacarne, E Guidotti, R Danesi, M Del Tacca
Clinical pharmacokinetics 49, 439-447, 2010
962010
A pharmacokinetic‐based test to prevent severe 5‐fluorouracil toxicity
G Bocci, C Barbara, F Vannozzi, A Di Paolo, A Melosi, G Barsanti, ...
Clinical Pharmacology & Therapeutics 80 (4), 384-395, 2006
942006
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo
G Bocci, R Danesi, U Benelli, F Innocenti, A Di Paolo, S Fogli, ...
Cancer chemotherapy and pharmacology 43, 205-212, 1999
941999
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
G Allegrini, A Falcone, A Fioravanti, MT Barletta, P Orlandi, F Loupakis, ...
British journal of cancer 98 (8), 1312-1319, 2008
912008
Concise review: chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment
E Arrigoni, M Del Re, S Galimberti, G Restante, E Rofi, S Crucitta, ...
Stem cells translational medicine 7 (3), 305-314, 2018
902018
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma
S Fogli, R Danesi, F Innocenti, A Di Paolo, G Bocci, C Barbara, ...
Therapeutic drug monitoring 21 (3), 367, 1999
901999
Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients
A Falcone, A Di Paolo, G Masi, G Allegrini, R Danesi, M Lencioni, ...
Journal of clinical oncology 19 (15), 3456-3462, 2001
872001
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
G Allegrini, T Di Desidero, MT Barletta, A Fioravanti, P Orlandi, B Canu, ...
Angiogenesis 15, 275-286, 2012
822012
The system can't perform the operation now. Try again later.
Articles 1–20